This is What Makes Disc Medicine Inc Stocks A Gamechanger?

Kevin Freeman

Disc Medicine Inc [IRON] stock is trading at $89.95, up 3.34%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The IRON shares have gain 7.27% over the last week, with a monthly amount glided 20.97%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Previously, Truist started tracking the stock with Buy rating on July 21, 2025, and set its price target to $86. TD Cowen initiated its recommendation with a Buy. Morgan Stanley upgraded its rating to Overweight for this stock on November 05, 2024, but kept the price target unchanged to $85. In a note dated November 04, 2024, Raymond James upgraded an Strong Buy rating on this stock and boosted its target price from $66 to $110.

Disc Medicine Inc [IRON] stock has fluctuated between $30.82 and $95.95 over the past year. Currently, Wall Street analysts expect the stock to reach $121.25 within the next 12 months. Disc Medicine Inc [NASDAQ: IRON] shares were valued at $89.95 at the most recent close of the market. An investor can expect a potential return of 34.8% based on the average IRON price forecast.

Analyzing the IRON fundamentals

To continue investigating profitability, this company’s Return on Assets is posted at -0.29, Equity is -0.32 and Total Capital is -0.34. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.05.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 87.64 points at the first support level, and at 85.32 for the second support level. However, for the 1st resistance point, the stock is sitting at 91.56, and for the 2nd resistance point, it is at 93.16.

Ratios To Look Out For

For context, Disc Medicine Inc’s Current Ratio is 23.45. Further, the Quick Ratio stands at 23.45, while the Cash Ratio is 5.26.

Transactions by insiders

Recent insider trading involved Yu Jonathan Yen-Wen, Chief Operating Officer, that happened on Nov 11 ’25 when 30000.0 shares were sold. Officer, JONATHAN YU completed a deal on Nov 11 ’25 to buy 30000.0 shares. Meanwhile, 10% Owner AI DMI LLC sold 0.74 million shares on Oct 22 ’25.

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.